Opsoclonus-myoclonus in children associated or not with neuroblastoma

European Journal of Paediatric Neurology

Volumn 14, Issue 5, 2010, Pages 400-409

  Krug, Pauline ^a   Schleiermacher, Gudrun ^a   Michon, Jean ^a   Valteau Couanet, Dominique ^b   Brisse, Hervé ^a   Peuchmaur, Michel ^c   Sarnacki, Sabine ^d,e   Martelli, Hélne ^f   Desguerre, Isabelle ^d   Tardieu, Marc ^f,g  

^a INSTITUT CURIE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e University Paris Descartes   (France)

^f BICÊTRE HOSPITAL   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Dancing eye syndrome; Developmental delay; Neuroblastoma; Opsoclonus myoclonus syndrome

Indexed keywords

CARBOPLATIN; CLONAZEPAM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIAZEPAM; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PLATINUM; PREDNISONE; RITUXIMAB; VINCRISTINE;

APRAXIA; ARM MOVEMENT; ARTICLE; ATAXIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; GAIT; HAND FUNCTION; HUMAN; LANGUAGE DISABILITY; MALE; MOOD DISORDER; MOTOR DYSFUNCTION; MYOCLONUS; NEUROBLASTOMA; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SLEEP DISORDER; STANDING; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROBLASTOMA; OPSOCLONUS-MYOCLONUS SYNDROME; RETROSPECTIVE STUDIES;

EID: 77956649451     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2009.12.005     Document Type: Article

References (29)

1. D. Plantaz, J. Michon, D. Valteau-Couanet, C. Coze, P. Chastagner, and C. Bergeron [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists] Arch Pediatr 7 6 2000 621 628
2. K.K. Matthay, F. Blaes, B. Hero, D. Plantaz, P. De Alarcon, and W.G. Mitchell Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004 Cancer Lett 228 1-2 2005 275 282
3. K.R. Pohl, J. Pritchard, and J. Wilson Neurological sequelae of the dancing eye syndrome Eur J Pediatr 155 3 1996 237 244
4. P. Dassan, C. Clarke, and D.J. Sharp A case of poststreptococcal opsoclonus-myoclonus syndrome Mov Disord 22 10 2007 1490 1491
5. L. Peter, J. Jung, C. Tilikete, P. Ryvlin, and F. Mauguiere Opsoclonus-myoclonus as a manifestation of Lyme disease J Neurol Neurosurg Psychiatr 77 9 2006 1090 1091
6. J. Chemli, S. Ketata, A. Dalhoumi, H. Ajmi, S. Hassayoun, and I. Fodha [Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection.] Arch Pediatr 14 8 2007 1003 1006
7. I. Zaganas, G. Prinianakis, N. Xirouchaki, and M. Mavridis Opsoclonus-myoclonus syndrome associated with cytomegalovirus encephalitis Neurology 68 19 2007 1636
8. V. Medrano, C. Royo-Villanova, J.J. Flores-Ruiz, A.P. Sempere, and S. Mola-Caballero de Roda [Parainfectious opsoclonus-myoclonus syndrome secondary to varicella-zoster virus infection] Rev Neurol 41 8 2005 507 508
9. R. van Toorn, H. Rabie, and J.M. Warwick Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy - possible immune reconstitution inflammatory syndrome Eur J Paediatr Neurol 9 6 2005 423 426
10. M.R. Pranzatelli The neurobiology of the opsoclonus-myoclonus syndrome Clin Neuropharmacol 15 3 1992 186 228
11. M.R. Pranzatelli, E.D. Tate, A. Wheeler, N. Bass, A.P. Gold, and M.L. Griebel Screening for autoantibodies in children with opsoclonus-myoclonus- ataxia Pediatr Neurol 27 5 2002 384 387
12. M.R. Pranzatelli, A.L. Travelstead, E.D. Tate, T.J. Allison, E.J. Moticka, and D.N. Franz B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes Neurology 62 9 2004 1526 1532
13. L. Raffaghello, M. Conte, E. De Grandis, and V. Pistoia Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma Eur J Paediatr Neurol 2008
14. N.L. Antunes, Y. Khakoo, K.K. Matthay, R.C. Seeger, D.O. Stram, and E. Gerstner Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus J Pediatr Hematol Oncol 22 4 2000 315 320
15. E. Rudnick, Y. Khakoo, N.L. Antunes, R.C. Seeger, G.M. Brodeur, and H. Shimada Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study Med Pediatr Oncol 36 6 2001 612 622
16. P.S. Koh, J.G. Raffensperger, S. Berry, M.B. Larsen, H.S. Johnstone, and P. Chou Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma J Pediatr 125 5 Pt 1 1994 712 716
17. K. Hayward, R.J. Jeremy, S. Jenkins, A.J. Barkovich, S.H. Gultekin, and J. Kramer Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies J Pediatr 139 4 2001 552 559
18. M.R. Pranzatelli, E.D. Tate, A.L. Travelstead, and D. Longee Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome Pediatrics 115 1 2005 e115 e119
19. M.R. Pranzatelli, E.D. Tate, A.L. Travelstead, J. Barbosa, R.A. Bergamini, and L. Civitello Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome J Pediatr Hematol Oncol 28 9 2006 585 593
20. K. Rostasy, B. Wilken, M. Baumann, K. Muller-Deile, I. Bieber, and J. Gartner High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome Neuropediatrics 37 5 2006 291 295
21. J. Bell, C. Moran, and J. Blatt Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus Pediatr Blood Cancer 2006
22. M.J. Burke, and S.L. Cohn Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma Pediatr Blood Cancer 2006
23. B. Wilken, M. Baumann, C.G. Bien, B. Hero, K. Rostasy, and F. Hanefeld Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses Eur J Paediatr Neurol 2007
24. M.S. Hammer, M.B. Larsen, and C.V. Stack Outcome of children with opsoclonus-myoclonus regardless of etiology Pediatr Neurol 13 1 1995 21 24
25. J.F. Swart, J. de Kraker, and N. van der Lely Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome Eur J Pediatr 161 5 2002 255 258
26. H. Brisse, V. Edeline, J. Michon, D. Couanet, J. Zucker, and S. Neuenschwander [Current strategy for the imaging of neuroblastoma] J Radiol 82 4 2001 447 454
27. F. Ertle, W. Behnisch, N.A. Al Mulla, M. Bessisso, D. Rating, and G. Mechtersheimer Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses Pediatr Blood Cancer 50 3 2008 683 687
28. C. Russo, S.L. Cohn, M.J. Petruzzi, and P.A. de Alarcon Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group Med Pediatr Oncol 28 4 1997 284 288
29. W.G. Mitchell, Y. Davalos-Gonzalez, V.L. Brumm, S.K. Aller, E. Burger, and S.B. Turkel Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae Pediatrics 109 1 2002 86 98